U.S. - Medicaments Containing Penicillins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments Containing Penicillin Prices in the United States
U.S. Medicaments Containing Penicillin Import Price per Ton in August 2022
In August 2022, the medicaments containing penicillin price per ton stood at $180.8K (CIF, US), with an increase of 247% against the previous month. Over the period under review, the import price recorded a significant increase. As a result, import price attained the peak level and is likely to continue growth in the immediate term.
As there is only one major supplying country, the average price level is determined by prices for India.
From January 2022 to August 2022, the rate of growth in terms of prices for China amounted to +17.3% per month.
U.S. Medicaments Containing Penicillin Imports
In August 2022, the amount of medicaments containing penicillins or derivatives thereof imported into the United States declined remarkably to 73 kg, reducing by -99.6% compared with the previous month's figure. Overall, imports faced a dramatic contraction. The pace of growth was the most pronounced in June 2022 with an increase of 95% month-to-month.
In value terms, medicaments containing penicillin imports dropped dramatically to $13K (IndexBox estimates) in August 2022. Over the period under review, imports continue to indicate a dramatic setback. The most prominent rate of growth was recorded in March 2022 when imports increased by 263% m-o-m.
U.S. Medicaments Containing Penicillin Imports by Country
In August 2022, India (73 kg) was the main medicaments containing penicillin supplier to the United States, with a approximately 100% share of total imports.
From January 2022 to August 2022, the average monthly rate of growth in terms of volume from India was relatively modest.
In value terms, India ($13K) constituted the largest supplier of medicaments containing penicillin to the United States.
From January 2022 to August 2022, the average monthly growth rate of value from India was relatively modest.
This report provides an in-depth analysis of the medicaments containing penicillin market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201130 - Medicaments containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives, for therapeutic or prophylactic uses, n.p.r.s.
Country coverage:
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORTS
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
315
This report provides an in-depth analysis of the medicaments containing penicillin market in the U.S..
215
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the U.S..
132
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in the U.S..
124
This report provides an in-depth analysis of the market for medicaments of other antibiotics in the U.S..
292
This report provides an in-depth analysis of the medicaments containing hormones market in the U.S..
307
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
447
This report provides an in-depth analysis of the global medicaments containing penicillin market.
230
This report provides an in-depth analysis of the global market for other medicaments for therapeutic or prophylactic uses.
306
This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.
182
This report provides an in-depth analysis of the global market for medicaments of other antibiotics.
68
Eli Lilly reports strong Q4 2024 earnings, boosts 2025 guidance; driven by impressive GLP-1 drug sales, it remains an attractive investment opportunity.
270
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
191
Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.
129
Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.
229
Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.
178
Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.
68
Eli Lilly reports strong Q4 2024 earnings, boosts 2025 guidance; driven by impressive GLP-1 drug sales, it remains an attractive investment opportunity.
270
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
191
Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.
129
Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.
